TAMOXIFEN FLARE IN ADVANCED ENDOMETRIAL CARCINOMA

被引：5

作者：

BROOKS, BJ ^{[1
]}

LIPPMAN, ME ^{[1
]}

机构：

[1] NCI,DIV CANC TREATMENT,MED BRANCH,CLIN ONCOL PROGRAM,BETHESDA,MD 20205

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1985年 / 3卷 / 02期

关键词：

D O I：

10.1200/JCO.1985.3.2.222

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：222 / 223

页数：2

共 12 条

[1] DO ESTROGEN AND PROGESTERONE RECEPTORS (E2R AND PR) IN METASTASIZING ENDOMETRIAL CANCERS PREDICT THE RESPONSE TO GESTAGEN THERAPY [J].

BENRAAD, TJ ;

FRIBERG, LG ;

KOENDERS, AJM ;

KULLANDER, S .

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1980, 59 (02) :155-159

[2]

BRUCHOVSKY N, 1983, DRUG HORMONE RESISTA, P2178

[3]

HARPER MJK, 1967, J REPROD FERTIL, V13, P101

[4] TAMOXIFEN (ANTIESTROGEN) THERAPY IN ADVANCED BREAST-CANCER [J].

KIANG, DT ;

KENNEDY, BJ .

ANNALS OF INTERNAL MEDICINE, 1977, 87 (06) :687-690

[5]

PEREZ CA, 1982, CANCER PRINCIPLES PR, P823

[6] TAMOXIFEN FLARE IN ADVANCED BREAST-CANCER [J].

PLOTKIN, D ;

LECHNER, JJ ;

JUNG, WE ;

ROSEN, PJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1978, 240 (24) :2644-2646

[7]

REIFENSTEIN EC, 1971, CANCER-AM CANCER SOC, V27, P485, DOI 10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO

[8]

2-1

[9]

STOLL BA, 1980, ENDOCRINE TREATMENT, V17, P149

[10]

SWENERTON KD, 1980, CANCER TREAT REP, V64, P761

← 1 2 →